Safety of Tranexamic Acid in Reducing Blood Loss Myomectomy.

Not Applicable

• Conditions: Myoma
• Interventions: Drug: women receiving misoprostol; Drug: women receiving tranexamic acid

• Registration Number: NCT04694677
• Lead Sponsor: Aljazeera Hospital

Brief Summary

Uterine leiomyomas (fibroids) are the most common benign tumors among women . Fibroids are found in approximately 15% to 30% of women in the reproductive age group

Detailed Description

Although most of them are asymptomatic, 20-50% of fibroids may cause problems such as heavy menstrual bleeding, anemia, pelvic pain, pressure symptoms from extrinsic compression of the colorectal and urinary tract, infertility, and recurrent pregnancy losses, where surgical intervention is often indicated

Study Timeline

• Status Verified: 2021-01
• Study First Submitted: 2021-01-02
• Study First Submitted QC: 2021-01-02
• Last Update Submitted: 2021-01-02
• Study First Posted: 2021-01-05
• Last Update Posted: 2021-01-05
• Study Start: 2021-01-10
• Primary Completion: 2021-08-15
• Study Completion: 2021-09-10

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

• women with myomas

Exclusion Criteria

• with with malignant lesions

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
women receiving misoprostol	women receiving misoprostol	-
women receiving tranexamic acid	women receiving tranexamic acid	-

Primary Outcome Measures

Name	Time	Method
the number of women who will have less blood loss	48 hours	how many women will have less blood loss

Trial Locations

Locations (1)

Algazeerah; 🇪🇬 Giza, Egypt